中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

文献类型:期刊论文

作者Galling, Britta ; Roldan, Alexandra ; Rietschel, Liz ; Hagi, Katsuhiko ; Walyzada, Frozan ; Zheng, Wei ; Cao, Xiao-Lan ; Xiang, Yu-Tao ; Kane, John M. ; Correll, Christoph U.
刊名EXPERT OPINION ON DRUG SAFETY
出版日期2016
卷号15期号:5页码:591-612
ISSN号1474-0338
学科主题Pharmacology & Pharmacy
语种英语
公开日期2016-12-16
源URL[http://ir.gibh.ac.cn/handle/344009/856]  
专题广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文
推荐引用方式
GB/T 7714
Galling, Britta,Roldan, Alexandra,Rietschel, Liz,et al. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials[J]. EXPERT OPINION ON DRUG SAFETY,2016,15(5):591-612.
APA Galling, Britta.,Roldan, Alexandra.,Rietschel, Liz.,Hagi, Katsuhiko.,Walyzada, Frozan.,...&Correll, Christoph U..(2016).Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.EXPERT OPINION ON DRUG SAFETY,15(5),591-612.
MLA Galling, Britta,et al."Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials".EXPERT OPINION ON DRUG SAFETY 15.5(2016):591-612.

入库方式: OAI收割

来源:广州生物医药与健康研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。